Markets
RPRX

Royalty Pharma Plc Bottom Line Advances In Q4

February 11, 2026 — 07:19 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Royalty Pharma plc (RPRX) announced earnings for its fourth quarter that Increased from the same period last year

The company's earnings totaled $214 million. This compares with $208 million last year.

The company's revenue for the period rose 4.7% to $622 million from $594 million last year.

Royalty Pharma plc earnings at glance (GAAP):

-Earnings: $214 Mln. vs. $208 Mln. last year. -Revenue: $622 Mln vs. $594 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

RPRX

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.